Increasing awareness about the importance of bone and joint health among consumers is driving the demand for bone & joint health supplements. Additionally, the rising prevalence of bone-related disorders such as osteoporosis and arthritis is fueling the growth of the market. Moreover, the aging population worldwide is also contributing to the expansion of the bone & joint health supplements market.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Product, Form, Consumer, Distribution Channel |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Bayer AG, Amway, BASF SE, Vita Life Sciences, Glanbia plc, Arazo Nutrition, Reckitt Benckiser Group plc, Natures Bounty,, NOW Foods, GNC Holdings, LLC |
Stringent regulations imposed by government authorities regarding the ingredients used in bone & joint health supplements are acting as a major restraint for the market. Furthermore, the high cost associated with quality bone & joint health supplements is hindering the market growth.